MACK DAVID J. 4
4 · BioXcel Therapeutics, Inc. · Filed Feb 4, 2025
Insider Transaction Report
Form 4
MACK DAVID J.
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-01-31−27,089→ 243,810 total→ Common Stock (27,089 underlying) - Exercise/Conversion
Common Stock
2025-01-31+27,089→ 81,267 total
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]On November 21, 2024, the Reporting Person was granted 325,077 RSUs, vesting in twelve equal installments on the last date of each month beginning on November 30, 2024, subject to his continued service as a Director through the vesting period.